CBDD Stock Overview
CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CBD of Denver Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0012 |
| 52 Week High | US$0.0024 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | 136.00% |
| 3 Month Change | 96.67% |
| 1 Year Change | 293.33% |
| 3 Year Change | -91.06% |
| 5 Year Change | 47.50% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBDD | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -21.3% | -2.3% | -3.7% |
| 1Y | 293.3% | 11.4% | 20.2% |
Return vs Industry: CBDD exceeded the US Pharmaceuticals industry which returned 11.4% over the past year.
Return vs Market: CBDD exceeded the US Market which returned 20.2% over the past year.
Price Volatility
| CBDD volatility | |
|---|---|
| CBDD Average Weekly Movement | 40.9% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CBDD's share price has been volatile over the past 3 months.
Volatility Over Time: CBDD's weekly volatility (41%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Paul Gurney | www.cbdofdenver.com |
CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. The company was formerly known as Verde Media Group, Inc. and changed its name to CBD of Denver Inc. in 2018.
CBD of Denver Inc. Fundamentals Summary
| CBDD fundamental statistics | |
|---|---|
| Market cap | US$9.35m |
| Earnings (TTM) | -US$503.32k |
| Revenue (TTM) | US$42.50k |
0.0x
P/S Ratio0.0x
P/E RatioIs CBDD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBDD income statement (TTM) | |
|---|---|
| Revenue | US$42.50k |
| Cost of Revenue | US$31.00k |
| Gross Profit | US$11.50k |
| Other Expenses | US$514.82k |
| Earnings | -US$503.32k |
Last Reported Earnings
Dec 31, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CBDD perform over the long term?
See historical performance and comparison